Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nabriva Therapeutics Plc | 158,270 | reported | 23 Jun 2017 | tx 6+924,582 |
| Nabriva Therapeutics AG | 36,523 | reported | 02 Aug 2022 | tx 21+528,865−104,788 |
| VIROPHARMA INC | 0 | reported | 24 Jan 2014 | tx 125+1,369,115−1,516,140 |
| NPS PHARMACEUTICALS INC | 0 | reported | 21 Feb 2015 | tx 26+134,973−115,176 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Aug 2022 | SALE | Nabriva Therapeutics AG | 5,339 | 0.19 USD | |
| 02 Aug 2021 | SALE | Nabriva Therapeutics AG | 531 | 1.20 USD | |
| 28 Jul 2021 | GRANT_AWARD | Nabriva Therapeutics AG | 17,500 | 0.00 USD | |
| 28 Jul 2021 | GRANT_AWARD | Nabriva Therapeutics AG | 35,000 | 0.00 USD | deriv |
| 19 Aug 2020 | EXERCISE | Nabriva Therapeutics AG | 33,750 | — | |
| 20 Aug 2020 | SALE | Nabriva Therapeutics AG | 11,064 | 0.65 USD | |
| 19 Aug 2020 | EXERCISE | Nabriva Therapeutics AG | 33,750 | 0.00 USD | deriv |
| 29 Jul 2020 | GRANT_AWARD | Nabriva Therapeutics AG | 17,500 | 0.00 USD | |
| 29 Jul 2020 | GRANT_AWARD | Nabriva Therapeutics AG | 35,000 | 0.00 USD | deriv |
| 30 Aug 2019 | PURCHASE | Nabriva Therapeutics AG | 10,177 | 2.03 USD | first after silence |
| 21 Aug 2019 | TAX_WITHHOLDING | Nabriva Therapeutics AG | 10,177 | 2.07 USD | |
| 19 Aug 2019 | EXERCISE | Nabriva Therapeutics AG | 33,750 | — | |
| 19 Aug 2019 | EXERCISE | Nabriva Therapeutics AG | 33,750 | 0.00 USD | deriv |
| 31 Jul 2019 | GRANT_AWARD | Nabriva Therapeutics AG | 35,000 | 0.00 USD | deriv |
| 22 Jun 2018 | PURCHASE | Nabriva Therapeutics AG | 5,000 | 3.72 USD | |
| 23 May 2018 | PURCHASE | Nabriva Therapeutics AG | 10,000 | 4.60 USD | |
| 31 Jan 2018 | GRANT_AWARD | Nabriva Therapeutics AG | 67,500 | 0.00 USD | deriv |
| 31 Jan 2018 | GRANT_AWARD | Nabriva Therapeutics AG | 200,000 | 0.00 USD | deriv |
| 22 Sept 2017 | PURCHASE | Nabriva Therapeutics AG | 2,588 | 8.35 USD | |
| 23 Jun 2017 | OTHER | Nabriva Therapeutics Plc | 1,595 | 0.00 USD | |
| 23 Jun 2017 | OTHER | Nabriva Therapeutics Plc | 155,817 | 0.00 USD | |
| 23 Jun 2017 | OTHER | Nabriva Therapeutics Plc | 151,000 | 0.00 USD | deriv |
| 23 Jun 2017 | OTHER | Nabriva Therapeutics Plc | 196,900 | 0.00 USD | deriv |
| 23 Jun 2017 | OTHER | Nabriva Therapeutics Plc | 158,270 | 0.00 USD | deriv |
| 23 Jun 2017 | OTHER | Nabriva Therapeutics Plc | 261,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 30 Aug 2019.